114 related articles for article (PubMed ID: 1318311)
21. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
Koga M; Eisman JA; Sutherland RL
Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
[TBL] [Abstract][Full Text] [Related]
22. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
Gniadecki R
Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
[TBL] [Abstract][Full Text] [Related]
23. Biphasic effect of 1,25-dihydroxyvitamin D3 on primary mouse epidermal keratinocyte proliferation.
Bollag WB; Ducote J; Harmon CS
J Cell Physiol; 1995 May; 163(2):248-56. PubMed ID: 7706369
[TBL] [Abstract][Full Text] [Related]
24. 1 alpha,25-dihydroxyvitamin D3 inhibits normal human keratinocyte growth by increasing transforming growth factor beta 2 release.
Haugen JD; Pittelkow MR; Zinsmeister AR; Kumar R
Biochem Biophys Res Commun; 1996 Dec; 229(2):618-23. PubMed ID: 8954947
[TBL] [Abstract][Full Text] [Related]
25. Time-course study of 1,25-(OH)2-vitamin D3 induction of homologous receptor and c-myc in nontransformed and transformed C3H/10T1/2 cell clones.
Paatero GI; Trydal T; Karlstedt KA; Aarskog D; Lillehaug JR
Int J Biochem; 1994 Mar; 26(3):367-74. PubMed ID: 8187933
[TBL] [Abstract][Full Text] [Related]
26. 1,25-Dihydroxyvitamin D3 induces 25-hydroxyvitamin D3-24-hydroxylase in a cultured monkey kidney cell line (LLC-MK2) apparently deficient in the high affinity receptor for the hormone.
Chandler JS; Chandler SK; Pike JW; Haussler MR
J Biol Chem; 1984 Feb; 259(4):2214-22. PubMed ID: 6321462
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.
Sølvsten H; Svendsen ML; Fogh K; Kragballe K
Arch Dermatol Res; 1997 May; 289(6):367-72. PubMed ID: 9209684
[TBL] [Abstract][Full Text] [Related]
28. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
Sørensen S; Sølvsten H; Politi Y; Kragballe K
Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395
[TBL] [Abstract][Full Text] [Related]
29. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor.
Ratnam AV; Bikle DD; Su MJ; Pillai S
J Invest Dermatol; 1996 Mar; 106(3):522-5. PubMed ID: 8648187
[TBL] [Abstract][Full Text] [Related]
30. The ovary: a target organ for 1,25-dihydroxyvitamin D3.
Dokoh S; Donaldson CA; Marion SL; Pike JW; Haussler MR
Endocrinology; 1983 Jan; 112(1):200-6. PubMed ID: 6291916
[TBL] [Abstract][Full Text] [Related]
31. Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3.
Manolagas SC; Provvedini DM; Murray EJ; Murray SS; Tsonis PA; Spandidos DA
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):856-60. PubMed ID: 3027709
[TBL] [Abstract][Full Text] [Related]
32. 1,24(R)-dihydroxyvitamin D3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity.
Matsunaga T; Yamamoto M; Mimura H; Ohta T; Kiyoki M; Ohba T; Naruchi T; Hosoi J; Kuroki T
J Dermatol; 1990 Mar; 17(3):135-42. PubMed ID: 2162363
[TBL] [Abstract][Full Text] [Related]
33. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
[TBL] [Abstract][Full Text] [Related]
34. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of and response to 1,25 dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes: existence of a paracrine system for 1,25 dihydroxycholecalciferol.
Rizk-Rabin M; Zineb R; Zhor B; Michèle G; Jana P
J Cell Physiol; 1994 Apr; 159(1):131-41. PubMed ID: 8138581
[TBL] [Abstract][Full Text] [Related]
36. Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells.
van Leeuwen JP; Pols HA; Schilte JP; Visser TJ; Birkenhäger JC
Calcif Tissue Int; 1991 Jul; 49(1):35-42. PubMed ID: 1654178
[TBL] [Abstract][Full Text] [Related]
37. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
38. Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression.
Tong WM; Kállay E; Hofer H; Hulla W; Manhardt T; Peterlik M; Cross HS
Eur J Cancer; 1998 Dec; 34(13):2119-25. PubMed ID: 10070321
[TBL] [Abstract][Full Text] [Related]
39. The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3.
Fagan DL; Prehn JL; Adams JS; Jordan SC
Mol Endocrinol; 1991 Feb; 5(2):179-86. PubMed ID: 1645452
[TBL] [Abstract][Full Text] [Related]
40. 1,25-Dihydroxyvitamin D3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells.
Yamaoka K; Marion SL; Gallegos A; Haussler MR
Biochem Biophys Res Commun; 1986 Sep; 139(3):1292-8. PubMed ID: 3021153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
